Developing a diverse workforce to address Alzheimer's disease in underrepresented groups
Official title: HABS-HD - Core G - Development Core
Funded at University of North Texas Hlth Sci Ctr · NIH-10916344 · Data updated 2026-11-12
This study is all about helping people from African American and Hispanic communities who are affected by Alzheimer's disease by training healthcare workers to better understand and support their unique needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas Hlth Sci Ctr NIH-funded |
| Lab location | 1 site (Fort Worth, United States) |
| Project start | September 30, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $1,436,935 |
| NIH project number | 5U19AG078109-03 |
| Project ID | NIH-10916344 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults from African American and Hispanic backgrounds who are affected by Alzheimer's disease or related disorders.
✕Less likely to help
Patients who do not belong to underrepresented groups or who are not affected by Alzheimer's disease may not receive direct benefits from this research.
What this research studies
This research focuses on addressing the disproportionate impact of Alzheimer's disease and related disorders among underrepresented groups, particularly African American and Hispanic populations. It aims to create educational opportunities that will train a diverse workforce capable of effectively studying, diagnosing, and treating these conditions in older adults. The approach includes curating programs that enhance cultural competence and ensure that healthcare professionals are prepared to meet the unique needs of these communities. By fostering diversity in research and clinical practice, the project seeks to improve outcomes for individuals affected by Alzheimer's disease.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment of Alzheimer's disease for underrepresented populations, ultimately enhancing their quality of life.
How similar studies have gone: Previous research has shown that increasing diversity in healthcare and research can lead to better health outcomes for underrepresented populations, indicating a promising approach.
Where this research is happening
-
University of North Texas Hlth Sci Ctr
Fort Worth, United States Active
Researchers
- Principal investigator: O'bryant, Sid E — University of North Texas Hlth Sci Ctr
- Study coordinator: O'bryant, Sid E
Related research
Other NIH-funded projects on the same topics.
-
AIM-AHEAD Coordinating Center supports four core areas
This NIH grant funds a coordinating center to advance a multi-core effort that could benefit patients through streamlined research collaboration and data sharing.
-
The WNK1/OSR1 protein pathway's role in brain insulin use and age-related memory loss
This project will see if the WNK1/OSR1 protein pathway makes the aging brain use insulin and sugar less well and whether fixing that can help memory in Alzheimer’s-related conditions.
-
HBV prevention in community pharmacies: a first step in a low-resource setting
This pilot project tests whether hepatitis B screening and vaccination can be integrated into everyday community pharmacy services to reach more people.
-
Glutaredoxin and aging: how it affects cataracts and new treatment ideas
A research project explores how aging affects the lens of the eye and tests new ways to prevent or treat cataracts by studying antioxidant repair and inflammation.
-
Voltage-dependent potassium channels and tiny blood vessels in people
This NIH grant explores how special potassium channels control tiny blood vessels in adults, which could affect blood pressure and heart health.
-
Texas Center for Health Disparities: Building Leaders in Health Equity
Aims to grow and train more health disparities researchers at UNTHSC so they can better serve communities affected by AIDS, cancers, and cardiovascular diseases.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.